Document:

<PAGE>

                                                                   EXHIBIT 10.17

             SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT

                                  by and among

                                  PRIMIS, INC.,
                                J. DAVID GRISSOM,
                               WINDCREST PARTNERS,
                           CASSELBERRY PARTNERS, L.P.,
                                JG FUNDING, LLC,
                           RICHLAND VENTURES II, L.P.,
           SOUTH ATLANTIC PRIVATE EQUITY FUND IV, LIMITED PARTNERSHIP,
       SOUTH ATLANTIC PRIVATE EQUITY FUND IV (Q.P.), LIMITED PARTNERSHIP,
                         MOORE GLOBAL INVESTMENTS, LTD.,
                     REMINGTON INVESTMENTS STRATEGIES, L.P.,
                                  JACK TYRRELL,
                               VICKI L. BRAKEBILL,
                             W. PATRICK ORTALE, III,
                            MICHAEL P. DECHANT, SR.,
                                       and
                               WILLIAM B. BRITAIN

                                 October 7, 1999

<PAGE>

                                TABLE OF CONTENTS

<TABLE>
<CAPTION>

                                                                                                               PAGE

<S>      <C>                                                                                                     <C>
1.       Sale and Issuance of Common Stock........................................................................1

2.       Closing..................................................................................................2

3.       Closing Items............................................................................................2

4.       Further Assurances.......................................................................................2

5.       Representations and Warranties of Company................................................................2
         A.       Corporate Standing..............................................................................2
         B.       Authorization...................................................................................3
         C.       Capitalization..................................................................................3
         D.       Validly Issued Shares...........................................................................4
         E.       No Conflict.....................................................................................4
         F.       Contracts and Other Commitments; Compliance.....................................................4
         G.       Subsidiaries....................................................................................4
         H.       Consents........................................................................................5
         I.       Financial Statements............................................................................5
         J.       Indebtedness for Borrowed Money; No Undisclosed Liabilities.....................................5
         K.       Title to Property and Assets; Leases............................................................5
         L.       Legal Proceedings...............................................................................5
         M.       Environmental Matters...........................................................................6
         N.       Licenses and Permits; Compliance with Laws......................................................6
         O.       Employee Benefit Plans..........................................................................6
         P.       Labor Relations.................................................................................6
         Q.       Insurance.......................................................................................7
         R.       Tax Matters.....................................................................................7
         S.       Patents and Trademarks..........................................................................7
         T.       Related-Party Transactions......................................................................8
         U.       Software Products...............................................................................8
         V.       Brokers' and Finders' Fees......................................................................9
         W.       Material Facts..................................................................................9

6.       Representations and Warranties of Investors..............................................................9
         A.       Binding Agreement...............................................................................9
         B.       Investment Representations......................................................................9

</TABLE>

                                        i

<PAGE>

<TABLE>

<S>      <C>      <C>                                                                                            <C>
         C.       Accredited Investor; Residence..................................................................9
         D.       Receipt of Information; Restricted Securities...................................................9
         E.       Investment Experience...........................................................................9
         F.       Legends........................................................................................10

7.       Survival of Representations and Warranties..............................................................10

8.       Indemnification.........................................................................................10
         A.       Indemnification by Company.....................................................................10
         B.       Indemnification by Investors...................................................................11

9.       Company Covenants.......................................................................................11
         A.       Use of Proceeds................................................................................11
         B.       Financial Reporting............................................................................11
         C.       Termination of Covenants.......................................................................12
         D.       Reservation of Shares..........................................................................12

10.      Public Statements.......................................................................................12

11.      Notices.................................................................................................12

12.      Parties in Interest; Assignment.........................................................................14

13.      Construction; Governing Law.............................................................................14

14.      Entire Agreement; Amendment and Waiver..................................................................15

15.      Severability............................................................................................15

16.      Counterparts............................................................................................15

17.      Attorneys' Fees.........................................................................................15

18.      Rights of Investors.....................................................................................15

19.      Exculpation Among Investors.............................................................................15

</TABLE>

                                       ii

<PAGE>

Exhibits and Schedules

Schedule 1                 Investors' Investment at Closing

Exhibit A                  Articles of Amendment

Exhibit B                  Subscription Agreement

                                       iii

<PAGE>

             SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT

                  THIS SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE
AGREEMENT ("Agreement") is made and entered into as of the 7th day of October,
1999, by and among [i] PRIMIS, INC., a Georgia corporation ("Company"), and [ii]
CASSELBERRY PARTNERS, L.P., a Kentucky limited partnership, JG FUNDING, LLC, a
Kentucky limited liability company, WINDCREST PARTNERS, a New York limited
partnership, J. DAVID GRISSOM, an individual, RICHLAND VENTURES II, L.P., a
Delaware limited partnership, REMINGTON INVESTMENTS STRATEGIES, L.P., a _______
limited partnership, MOORE GLOBAL INVESTMENTS, LTD., a __________ limited
partnership, SOUTH ATLANTIC PRIVATE EQUITY FUND IV, LIMITED PARTNERSHIP, a
Delaware limited partnership, and SOUTH ATLANTIC PRIVATE EQUITY FUND IV (Q.P.),
LIMITED PARTNERSHIP, a Delaware limited partnership, JACK TYRRELL, individually,
VICKI L. BRAKEBILL, individually, W. PATRICK ORTALE, III, individually, MICHAEL
P. DECHANT, SR., individually, and WILLIAM B. BRITAIN, individually (each an
"Investor" and collectively the "Investors").

                  WITNESSETH:

                  Company desires to sell and issue, and each Investor desires
to purchase and acquire, the number of shares of Company's authorized but
unissued Series B Convertible Preferred stock ("Series B Preferred Stock") set
forth opposite his, her or its name on SCHEDULE 1 hereto, upon the terms and
subject to the conditions contained herein.

                  NOW, THEREFORE, in consideration of the mutual covenants,
representations and warranties herein contained, and intending to be legally
bound, Company and Investors agree as follows:

         1. SALE AND ISSUANCE OF COMMON STOCK.

                  A. Company shall adopt and file with the Georgia Secretary of
State on or before the Closing (as defined below) Articles of Amendment to the
Company's Articles of Incorporation in the form attached hereto as EXHIBIT A
(the "Articles of Amendment").

                  B. Subject to the terms and conditions of this Agreement, each
Investor agrees, severally and not jointly, to purchase from Company, and
Company agrees to sell, issue and deliver to each Investor, severally and not
jointly, the number of shares of Series B Preferred Stock set forth opposite
each Investor's name on SCHEDULE 1 attached hereto at a price of Six Dollars
($6.00) per share resulting in a total purchase price of approximately Four
Million Three Hundred Fifty Thousand Seven Hundred Eighty Dollars ($4,350,780).
Investors will pay the purchase price in immediately available funds in
accordance with the Subscription Agreement previously executed by him, her or it
and delivered to the Company. Certificates representing the shares of the Series
B Preferred Stock will be issued against receipt by the Company of payments of
the Purchase Price as contemplated by such Subscription Agreements.

<PAGE>

         2. CLOSING. The closing of the transactions contemplated by this
Agreement (the "Closing") shall take place at 10:00 a.m. on or about October
___, 1999, at the offices of Wyatt, Tarrant & Combs, 2800 Citizens Plaza,
Louisville, Kentucky, or at such other time, date, or place as shall be mutually
agreed upon by the parties hereto in writing (the "Closing Date").

         3. CLOSING ITEMS.

                  A.       At the Closing, Company shall deliver, or cause to be
         delivered, the following items:

                           [1] resolutions of the Board of Directors of Company
         authorizing the execution, delivery and consummation of this Agreement,
         the issuance of the shares of Series B Preferred Stock, and the other
         matters contemplated hereby, certified as to their due adoption and
         continued validity by the Secretary of Company;

                           [2] resolutions of the shareholders of Company
         authorizing the Articles of Amendment certified as to their due
         adoption and continued validity by the Secretary of the Company;

                           [3] a certificate executed by the President of
         Company to the effect that each of Company's representations and
         warranties in this Agreement was accurate in all respects as of the
         date of this Agreement and is accurate in all respects as of the
         Closing Date as if made on the Closing Date; and

                           [4] Executed counterpart of each Investor's
         Subscription Agreement substantially in the form attached hereto as
         EXHIBIT B.

         4. FURTHER ASSURANCES. Each party shall execute such additional
documents and take such other actions as the other party or parties may
reasonably request to consummate the transactions contemplated hereby and
otherwise as may be necessary to effectively carry out the terms and provisions
of this Agreement.

         5. REPRESENTATIONS AND WARRANTIES OF COMPANY. Except as set forth in
the disclosure letter dated the date hereof delivered to each Investor (the
"Disclosure Letter"), Company hereby represents and warrants to each Investor as
follows:

                  A. CORPORATE STANDING. Company is a corporation duly
organized, validly existing, and in good standing under the laws of Georgia.
Company has all requisite power and authority to own, lease and operate its
properties and to carry on its business as now being conducted and as presently
proposed to be conducted, to execute, deliver and perform this Agreement and any
other agreement to which Company is a party, the execution and delivery of which
is contemplated hereby (the "Ancillary Agreements"). Company is duly qualified
and is authorized to transact business and is in good standing as

                                       2
<PAGE>

a foreign corporation in each jurisdiction in which the failure so to qualify
would have a material adverse effect on its business, properties, prospects, or
financial condition. True and accurate copies of the articles of incorporation
and bylaws of Company (and all amendments thereto) and minute book (containing
the records of meetings and written consents of the stockholders, the board of
directors and any committees of the board of directors) of Company have
previously been made available to Investors.

                  B. AUTHORIZATION. The execution and delivery of this Agreement
and any Ancillary Agreement and the consummation of the transactions
contemplated hereby and thereby, have been duly authorized by all necessary
corporate action on the part of Company. Each of this Agreement and any
Ancillary Agreement have been duly executed and delivered by Company and
constitutes the legal, valid and binding obligation of Company enforceable
against it in accordance with its terms.

                  C. CAPITALIZATION. As of the Closing Date, the authorized
capital stock of Company shall consist of 14,920,000 shares, divided into: (i)
10,000,000 shares of Common Stock, par value $0.01 per share; (ii) 2,500,000
shares of preferred stock ("Preferred Stock") with such preferences, limitations
and relative rights as may be determined by the Board of Directors pursuant to
Article IV(B) of the Articles; (iii) 420,000 shares of Class A Convertible
Preferred Stock ("Class A Preferred"); and (iv) 2,000,000 shares of Series B
Convertible Preferred Stock. Immediately prior to the Closing, 100% of the
outstanding shares of Common Stock of the Company and 100% of the outstanding
shares of Series A Convertible Preferred Stock are owned by the stockholders and
in the amounts specified in Section 5.C of the Disclosure Letter and no shares
of Series B Convertible Preferred Stock , Class A Preferred Stock or other
Preferred Stock are outstanding.

                  Except as set forth in Section 5.C of the Disclosure Letter,
there are outstanding no subscriptions, options, warrants, calls, commitments or
rights (including conversion or preemptive rights and rights of first refusal),
proxy or stockholder agreements or agreements of any character relating to
shares of Company's capital stock or the Series B Preferred Stock to be issued
hereunder or any instruments that can be converted into shares of Company's
capital stock or the Series B Preferred Stock to be issued hereunder. None of
the shares of Company's capital stock have been issued in violation of any
preemptive right. All issuances, transfers or purchases of the capital stock of
Company have been in compliance with all applicable agreements and all
applicable laws, including federal and state securities laws, and all taxes
thereon, if any, have been paid. No former or present holder of any of the
shares of capital stock of Company has any legally cognizable claim against
Company based on any issuance, sale, purchase, redemption or involvement in any
transfer of any shares of capital stock by Company. There are no contractual
obligations of Company to repurchase, redeem or otherwise acquire any shares of
capital stock of Company. No bonds, debentures, notes or other indebtedness
having the right to vote (or convertible into or exercisable for securities
having the right to vote) on any matters on which shareholders of Company may
vote are issued or outstanding. Company is not a party to or subject to any
agreement or understanding, and, to Company's best knowledge, there is no
agreement or understanding between any persons that affects or relates to the
voting or giving of written consents with respect to any security or the voting
by any director of Company.

                                       3
<PAGE>

                  D. VALIDLY ISSUED SHARES. The shares of Series B Convertible
Preferred Stock to be issued, sold and delivered in accordance with the terms of
this Agreement for the consideration set out herein, will, upon issuance in
accordance with the terms hereof, be duly and validly issued, fully paid and
nonassessable, free of restrictions on transfer other than restrictions on
transfer under applicable federal and state securities laws and the existing
Amended and Restated Shareholders' Agreement dated June 16, 1998, by and among
the Company and its Shareholders. The issuance of the Series B Convertible
Preferred Stock to Investors pursuant to this Agreement will comply with all
applicable laws, including federal and state securities laws, and will not
violate the preemptive rights of any person. The shares of Common Stock issuable
upon conversion of the Series B Preferred Stock being purchased under this
Agreement will be, upon issuance and delivery in accordance with the terms of
the Articles of Incorporation, duly and validly issued, fully paid and
nonassessable and free of restrictions on transfer other than restrictions on
transfer under this Agreement, the Shareholders' Agreement and under applicable
federal and state securities laws (other than those created by investors). The
issuance of the shares of Common Stock upon conversion of the Series A Preferred
Stock will comply with all applicable laws, including federal and state
securities laws (assuming the accuracy of the representations set forth in
Section 6.B through 6.E of this Agreement as of the date of issuance of such
shares of Common Stock), and will not violate the preemptive rights of any
person.

                  The outstanding shares of Company's Common Stock and Series A
Preferred Stock have been duly authorized and validly issued, are fully paid and
nonassessable, and were issued in accordance with the registration or
qualification provisions of the applicable federal and state securities laws or
pursuant to valid exemptions therefrom.

                  E. NO CONFLICT. The execution and delivery of this Agreement
and any Ancillary Agreement do not, and the consummation of the transactions
contemplated hereby and thereby will not, conflict with, or result in any
violation of, or default (with or without notice or lapse of time, or both)
under, or give rise to a right of termination, cancellation or acceleration of
any obligation or the loss of a material benefit under, or the creation of a
lien, pledge, security interest, charge or other encumbrance on assets (any such
conflict, violation, default, right of termination, cancellation or
acceleration, loss or creation, a "Violation") pursuant to, any provision of the
Company's Articles of Incorporation or Bylaws, or result in any Violation of any
material lease, agreement, obligation, instrument, permit, concession,
franchise, license, judgment, order, decree, statute, law, ordinance, rule or
regulation applicable to Company, or Company's properties or assets.

                  F. CONTRACTS AND OTHER COMMITMENTS; COMPLIANCE. Company is not
in violation or default of any provision of its Articles of Incorporation or
Bylaws or in any respect of any provision of any material contract or other
items listed on the Disclosure Letter.

                  G. SUBSIDIARIES. Except as set forth in Section 5.G of the
Disclosure Letter, Company does not own or control, directly or indirectly, any
interest in any other corporation, partnership, limited

                                       4
<PAGE>

liability company, association or other business entity. Except as set forth in
Section 5.G of the Disclosure Letter, Company is not a participant in any joint
venture, partnership or similar arrangement.

                  H. CONSENTS. No consent, approval, qualification, order or
authorization of, or registration, declaration or filing with, any court,
administrative agency or commission or other governmental authority or
instrumentality, domestic or foreign, or other third party is required by or
with respect to Company in connection with the execution and delivery of this
Agreement, or the consummation by Company of the transactions contemplated
hereby, which has not already been obtained, except for notices of sale required
to be filed with the Securities and Exchange Commission, or such post closing
filings as may be required under applicable state securities laws which will be
timely filed within the applicable periods therefor.

                  I. FINANCIAL STATEMENTS. Company has delivered to Investors
prior to the date hereof its audited financial statements for the years ended
December 31, 1997 and December 31, 1998, and its unaudited financial statements
(balance sheet and profit and loss statement) for the six (6) month period ended
June 30, 1999 (the "Financial Statements"). The Financial Statements, including
any footnotes thereto, were prepared in accordance with generally accepted
accounting principles and fairly present the financial position and operating
results of Company as of the dates and for the periods indicated therein. Since
June 30, 1999, there has not been any material adverse change in the assets,
liabilities, financial condition, results of operation or prospects of Company.

                  J. INDEBTEDNESS FOR BORROWED MONEY; NO UNDISCLOSED
LIABILITIES. Except as and to the extent reflected and adequately reserved
against in the Financial Statements, and except as set forth in Section 5.J of
the Disclosure Letter, as of the Closing Date, Company has no direct or indirect
indebtedness for borrowed money, indebtedness by way of lease-purchase
arrangements, guarantees, undertakings, chattel mortgages or other security
arrangements with any bank, financial institution or other third party and
Company will not have any liability or obligation whatsoever, whether accrued,
absolute, contingent or otherwise.

                  K. TITLE TO PROPERTY AND ASSETS; LEASES. Except as set forth
in Section 5.K of the Disclosure Letter, Company owns no real property in fee
simple. Company has good, valid and marketable title to all the personal and
mixed, tangible and intangible properties and assets which it purports to own,
free and clear of all liens, restrictions, claims, charges, security interests,
easements or other encumbrances of any nature whatsoever, except for liens for
current taxes not yet due and payable. With respect to the property and assets
that it leases, Company is in compliance with such leases and, to Company's
knowledge, holds a valid leasehold interest free and clear of any liens, claims
and encumbrances. All properties and assets of Company are in the possession or
control of Company, and no other person is entitled to possession of any such
properties and assets. Company is not bound or committed to make any capital
improvement or expenditure with respect to its owned or leased real or personal
property.

                                       5
<PAGE>

                  L. LEGAL PROCEEDINGS. Except as set forth in the Disclosure
Letter or which are not material to Company, there are no claims of any kind or
any actions, suits, proceedings, arbitrations or investigations pending or, to
Company's knowledge, threatened against or affecting Company or against any
asset, interest or right of Company or which questions the validity of the
transactions contemplated by this Agreement and Company knows of no facts which
may constitute a basis therefor.

                  M. ENVIRONMENTAL MATTERS. Company is not in violation of any
applicable statute, law or regulation relating to the environment or
occupational health and safety (the "Environmental Laws"), and, to Company's
knowledge, as of the date hereof no material expenditures are required to be
made by Company in order to comply with any of the Environmental Laws.

                  N. LICENSES AND PERMITS; COMPLIANCE WITH LAWS. Except as set
forth in Section 5.N of the Disclosure Letter, Company holds all franchises,
permits, licenses, variances, exemptions, orders and approvals of all
governmental entities which are material to the operation of Company's business
and is in compliance with the terms thereof. Company has complied with and is
not in any default under (and has not been charged with or received notice with
respect to, nor is threatened with or under investigation with respect to, any
charge concerning any violation of any provision of) any federal, state or local
law, regulation, ordinance, rule or order (whether executive, judicial,
legislative or administrative) or any order, writ, injunction or decree of any
court, agency or instrumentality and no action, suit, proceeding, hearing,
investigation, charge, complaint, claim, demand, or notice has been filed or
commenced against any of them alleging any failures to comply.

                  O. EMPLOYEE BENEFIT PLANS. Except as set forth in Section 5.O
of the Disclosure Letter, Company has no employee benefit plans including any
profit sharing, deferred compensation, incentive compensation, stock ownership,
stock purchase, phantom stock, retirement, vacation, severance, disability,
death benefit, hospitalization, medical or other plan, arrangement or
understanding (whether or not legally binding) providing benefits to any current
or former employee, officer or director of Company (collectively "Benefit
Plans"), or any employment, consulting, severance, termination or
indemnification agreement, arrangement or understanding between Company and any
officer, director or employee of Company. Each Benefit Plan has been adminis
tered in all material respects in accordance with its terms and all applicable
laws.

                  P. LABOR RELATIONS.

                           [1] Company is in compliance in all material respects
         with all applicable laws respecting employment and employment
         practices, terms and conditions of employment and wages and hours and
         occupational safety and health;

                           [2] There is no unfair labor practice charge or
         complaint or any other matter against or involving Company pending or,
         to Company's knowledge, threatened before the National Labor Relations
         Board or any court of law;

                                       6
<PAGE>

                           [3] There is no labor strike, dispute, slowdown or
         stoppage actually pending or, to Company's knowledge, threatened
         against Company;

                           [4] Company is not a party to or bound by any
         collective bargaining agreement or any similar labor union arrangement;

                           [5] There are no charges, investigations,
         administrative proceedings or formal complaints of discrimination
         (including discrimination based upon sex, age, marital status, race,
         color, religion, national origin, sexual preference, disability,
         handicap or veteran status) pending or, to Company's knowledge,
         threatened, before the Equal Employment Opportunity Commission or any
         federal, state or local agency or court against Company. There have
         been no governmental audits of the equal employment opportunity
         practices of Company and, to Company's knowledge, no basis for any such
         claim exists; and

                           [6] To Company's knowledge, Company is in compliance
         in all material respects with the requirements of the Americans With
         Disabilities Act.

                  Q. INSURANCE. Section 5.Q of the Disclosure Letter sets forth
a list of all insurance policies, including property, casualty, liability and
other insurance maintained with respect to the assets and business of Company
("Company Insurance"). Company is not liable for any material retroactive
premium adjustments with respect to any of its insurance policies or bonds. All
such policies and bonds are legal, valid and enforceable and in full force and
effect and Company is not in breach or default (including with respect to the
payment of premiums or the giving of notices) and no event has occurred which,
with notice or the lapse of time, would constitute such a breach or default, or
permit termination, modification or acceleration under the policy. Nor has the
Company received any notice of premium increases or cancellations with respect
to any of such policies and bonds. Company believes the amount and type of
Company Insurance coverage is adequate for Company's business and is consistent
with good business practice.

                  R. TAX MATTERS. Company has timely filed or caused to be filed
all federal, state, foreign and local income, franchise, gross receipts,
payroll, sales, use, withholding, occupancy, excise, real and personal property,
employment and other tax returns, tax information returns and reports ("Tax
Returns") required to be filed and all such Tax Returns were correct and
complete in all respects. Company has paid, or made adequate provisions for the
payment of, all taxes, duties or assessments of any nature whatsoever, interest
payments, penalties and additions (whether or not reflected in the returns as
filed) due and payable (and/or properly accruable for all periods ending on or
before the date of this Agreement) to any city, county, state, foreign country,
the United States or any other taxing authority. There are no security interests
on any of the assets of Company that arise in connection with any failure (or
alleged failure) to pay any tax. Company has withheld and paid all taxes
required to have been withheld and paid in connection with amounts paid or owing
to any employee, independent contractor, creditor, stockholder or other third
party. No deficiencies for any taxes have been proposed, asserted or assessed
against Company that are not adequately reserved for.

                                       7
<PAGE>

                  S. PATENTS AND TRADEMARKS. Company owns or possesses
sufficient legal rights to all patents, trademarks, service marks, trade names,
copyrights, trade secrets, licenses, information, and proprietary rights and
processes necessary for its business as now conducted and as proposed to be
conducted without any conflict with, or infringement of the rights of, others.
Except for agreements with its own employees or consultants and standard
end-user license agreements, if any, there are no outstanding options, licenses,
or agreements of any kind relating to the foregoing, nor is the Company bound by
or a party to any options, licenses, or agreements of any kind with respect to
the patents, trademarks, service marks, trade names, copyrights, trade secrets,
licenses, information, and proprietary rights and processes of any other person
or entity. Company has not received any communications alleging that Company has
violated or, by conducting its business as proposed, would violate any of the
patents, trademarks, service marks, trade names, copyrights, trade secrets, or
other proprietary rights or processes of any other person or entity. Company is
not aware that any of its employees is obligated under any contract (including
licenses, covenants, or commitments of any nature) or other agreement, or
subject to any judgment, decree, or order of any court or administrative agency,
that would interfere with the use of such employee's best efforts to promote the
interests of Company or that would conflict with Company's business as proposed
to be conducted. Neither the execution nor delivery of this Agreement, nor the
carrying on of Company's business by the employees of Company, nor the conduct
of Company's business as proposed, will, to Company's knowledge, conflict with
or result in a breach of the terms, conditions, or provisions of, or constitute
a default under, any contract, covenant, or instrument under which any of such
employees is now obligated. Company does not believe it is or will be necessary
to use any inventions of any of its employees (or persons it currently intends
to hire) made prior to their employment by Company. Each independent contractor,
employee and/or officer of Company who or which has contributed to the
development of the Computer Software (as defined below) has executed proprietary
information/confidentiality agreements.

                  T. RELATED-PARTY TRANSACTIONS. Except as set forth in Section
5.T of the Disclosure Letter, no employee, officer, or director of Company, or
member of his or her immediate family is indebted to Company, nor is Company
indebted (or committed to make loans or extend or guarantee credit) to any of
them. To Company's knowledge, none of such persons has any direct or indirect
ownership interest in any firm or corporation with which Company is affiliated
or with which Company has a business relationship, or any firm or corporation
that competes with Company, except that employees, officers, or directors of
Company, and members of their immediate families may own stock in publicly
traded companies that may compete with Company. Except as set forth in Section
5.T of the Disclosure Letter, no employee, officer or director of Company, or,
to Company's knowledge, any member of their immediate families is, directly or
indirectly, interested in any material contract with Company. For purposes of
this Agreement, Company shall be deemed to have knowledge of a fact, event,
condition, matter or situation if any of Company's officers or directors are
consciously aware of such fact, event, condition, matter or situation, as
appropriate.

                  U. SOFTWARE PRODUCTS. Company has received no customer
complaints concerning alleged defects in its computer appraisal software
products, including, without limitation, Value Express

                                       8
<PAGE>

(collectively, the "Computer Software") that, if true, would materially
adversely affect the operations or financial condition of Company.

                  V. BROKERS' AND FINDERS' FEES. Company has not employed any
broker, finder or financial advisor or incurred any liability for fees or
commissions payable to any broker, finder or financial advisor in connection
with the negotiations relating to or the transactions contemplated by this
Agreement.

                  W. MATERIAL FACTS. Company has provided each Investor with all
the information reasonably available to it that such Investor has requested for
deciding whether to purchase the Series B Preferred Stock. This Agreement and
the documents or written statements furnished by Company to Investors in
connection with the transactions contemplated hereby do not contain any untrue
statement of a material fact or omit to state any material fact necessary to
make the statements contained herein or therein, in light of the circumstances
in which they are made, not misleading.

         6. REPRESENTATIONS AND WARRANTIES OF INVESTORS. Each Investor hereby
represents and warrants to Company, severally and not jointly, as of the date
hereof, as follows:

                  A. BINDING AGREEMENT. This Agreement and any Ancillary
Agreement, as applicable, have been duly executed and delivered by such Investor
and each constitutes the legal, valid and binding obligation of such Investor
enforceable against him in accordance with its terms.

                  B. INVESTMENT REPRESENTATIONS. Such Investor is acquiring the
Series B Preferred Stock solely for its or his own account as principal, for
investment purposes only and not with a view to resale or distribution thereof
in whole or in part, and such Investor has no present intention of selling,
granting any participation in, or otherwise distributing the Securities.

                  C. ACCREDITED INVESTOR; RESIDENCE. Such Investor is a resident
of the state set forth under its or his name on SCHEDULE 1 attached hereto.

                  D. RECEIPT OF INFORMATION; RESTRICTED SECURITIES. Such
Investor acknowledges that the Series B Preferred Stock is not being and will
not be registered under the Securities Act of 1933, as amended (the "Securities
Act") or the securities laws of any other jurisdiction in reliance on exemptions
thereunder. The Series B Preferred Stock has not been and will not be approved
or disapproved by the Securities and Exchange Commission or any other
governmental authority or agency of any jurisdiction. Such Investor represents
that such Investor has had an opportunity to ask questions and receive answers
from Company regarding the terms and conditions of the offering of the Series B
Preferred Stock and the business, properties, prospects, and financial condition
of Company and to obtain additional information (to the extent Company possessed
such information or could acquire it without unreasonable effort or expense)
necessary to verify the accuracy of any information furnished to such Investor
or to which such Investor had access. Investors' representations under this
Section 6, however, shall not limit or modify the

                                       9
<PAGE>

representations and warranties of Company in Section 5 of this Agreement or the
right of Investors to rely thereon.

                  E. INVESTMENT EXPERIENCE. Such Investor is experienced in
evaluating and investing in private placement transactions of securities of
companies in a similar stage or development and acknowledges that such Investor
is able to fend for itself, can bear the economic risk of such Investor's
investment, and has such knowledge and experience in financial and business
matters that such Investor is capable of evaluating the merits and risks of the
investment in the Series B Preferred Stock.

                  F. LEGENDS. Each certificate or other document evidencing any
of the Common Stock issued pursuant to this Agreement shall be endorsed with the
legend set forth below:

         THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
         SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS
         AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, OR HYPOTHECATED
         UNLESS AND UNTIL REGISTERED UNDER SUCH ACT, OR UNLESS THE COMPANY HAS
         RECEIVED AN OPINION OF COUNSEL OR OTHER EVIDENCE, SATISFACTORY TO THE
         COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.

         AN AMENDED AND RESTATED AGREEMENT DATED AS OF JULY 16, 1998 HAS BEEN
         ENTERED INTO BY CERTAIN SHAREHOLDERS OF THE CORPORATION AND HAS BEEN
         DELIVERED TO THE SECRETARY TO BE KEPT ON FILE AT THE CORPORATION'S
         REGISTERED OFFICE. THAT AGREEMENT IMPOSES VARIOUS RESTRICTIONS UPON THE
         TRANSFER OF THE SHARES REPRESENTED BY THIS CERTIFICATE AND CREATES
         VARIOUS OPTIONS, RIGHTS AND INTERESTS WITH RESPECT TO THOSE SHARES.

         7. SURVIVAL OF REPRESENTATIONS AND WARRANTIES. All representations and
warranties contained in this Agreement by any party to this Agreement and any
certificate or other instrument delivered by or on behalf of any party pursuant
to this Agreement shall be continuous and shall survive the Closing and the
issuance of all shares of Company's capital stock. Each party shall have the
right to rely on each other party's representations and warranties made herein,
notwithstanding any investigation conducted by such party.

         8. INDEMNIFICATION.

                  A. INDEMNIFICATION BY COMPANY. Company shall indemnify and
reimburse each Investor for any and all claims, losses, liabilities, damages
(including, without limitation, fines, penalties, and criminal or civil
judgments and settlements), costs (including, without limitation, court costs)
and expenses

                                       10
<PAGE>

(including, without limitation, attorneys' and accountants' fees) (hereinafter
"Loss" or "Losses") suffered or incurred by such Investor, any successors or
assigns thereto (the "Protected Parties") as a result of, or with respect to:

                           [1] Any breach or inaccuracy of any representation or
         warranty of Company set forth in Section 5;

                           [2] Any breach of or noncompliance by Company with
         any covenant or agreement of Company contained in this Agreement; and

                           [3] any and all actions, suits, proceedings, claims,
         demands, assessments and judgments incident to any of the foregoing.

                  B. INDEMNIFICATION BY INVESTORS. Each Investor shall,
severally and not jointly, indemnify and reimburse Company for any and all
claims, losses, liabilities, damages (including, without limitation, fines,
penalties, and criminal or civil judgments and settlements), costs (including,
without limitation, court costs) and expenses (including, without limitation,
attorneys' and accountants' fees) (hereinafter "Loss" or "Losses") suffered or
incurred by Company or any successors or assigns thereto as a result of, or with
respect to:

                           [1] Any breach or inaccuracy of any representation or
         warranty of such Investor set forth in Section 6;

                           [2] Any breach of or noncompliance by such Investors
         with any covenant or agreement of Investor contained in this Agreement;
         and

                           [3] any and all actions, suits, proceedings, claims,
         demands, assessments and judgments incident to any of the foregoing.

         9. COMPANY COVENANTS. Company hereby covenants and agrees as follows:

                  A. USE OF PROCEEDS. The proceeds from the sale of the Series B
Preferred Stock pursuant to this Agreement shall be used by Company for working
capital, to make acquisitions and for other corporate purposes.

                  B. FINANCIAL REPORTING. Subject to Section 9.c, Company shall
furnish to the Investors:

                           [1] an audited balance sheet and statements of income
         and cash flow within ninety (90) days after the end of each fiscal
         year, together with comparative figures for the last preceding fiscal
         year prepared by a firm of certified public accountants acceptable from
         time to

                                       11
<PAGE>

         time to a majority in interest of the outstanding Series A Preferred
         Stock, Series B Preferred Stock and Common Stock of Company voting
         together as a single class on an as if converted basis;

                           [2] as soon as available, and in any event within
         thirty (30) days after the close of each calendar month, an unaudited
         balance sheet and statement of income and cash flows for such month,
         together with comparative figures for both the month just ended and the
         portion of the fiscal year then ended, and a written one or two page
         monthly summary of Company's operations. Such financial statements
         shall be prepared in accordance with generally accepted accounting
         principles consistently applied (subject to audit and year-end
         adjustments) by the principal financial or accounting officer of the
         Company;

                           [3] as soon as available, and in any event within
         thirty (30) days before the close of each fiscal year, a business plan
         and projections for Company's next fiscal year; and

                           [4] such additional information with respect to
         Company's financial condition as may be reasonably requested by the
         Investors.

                  C. TERMINATION OF COVENANTS. The covenants set forth in
Section 9.b shall terminate and be of no further force or effect at such time as
Company is required to file reports pursuant to Sections 13 or 15(d) of the
Securities Exchange Act of 1934.

                  D. RESERVATION OF SHARES. On and after the Closing Date,
Company will reserve and keep reserved at all times sufficient Shares of Common
Stock for issuance upon conversion of the Series B Preferred Stock. Immediately
prior to the occurrence of any event that would cause the number of Shares of
Common Stock or type of securities into which the Series B Preferred Stock would
be convertible, to be adjusted, Company shall take any and all actions necessary
to permit such conversion or exercise. Upon conversion of any s hares of Series
B Preferred Stock, Company will promptly issue and deliver the Shares of Common
Stock required to be delivered.

         10. PUBLIC STATEMENTS. Neither Company nor Investors shall, without the
prior written approval of the other parties hereto, make any press release or
other public announcement concerning the transactions contemplated by this
Agreement. Investors and Company may disclose information with respect to the
transaction contemplated hereby to their respective employees, agents,
consultants and third parties only to the extent such persons have a need to
know such information.

         11. NOTICES. All notices, requests, consents, and other communications
under this Agreement shall be in writing and shall be mailed by first class,
registered, or certified mail, postage prepaid, or sent via overnight courier
service, or delivered personally:

                                       12
<PAGE>

         If to Investors, to:           J. David Grissom
                                        c/o Mayfair Capital
                                        Suite 2510
                                        400 West Market Street
                                        Louisville, KY  40202

                                        Casselberry Partners, L.P.
                                        c/o Douglas F. Cobb
                                        600 West Main Street
                                        Louisville, KY  40202

                                        JG Funding, LLC
                                        1850 National City Tower
                                        101 South Fifth Street
                                        Louisville, KY  40202

                                        Windcrest Partners
                                        49th Floor
                                        122 East 42nd Street
                                        New York, NY  10168-0130

                                        Richland Ventures II, L.P.
                                        3100 West End Avenue, Suite 400
                                        Nashville, TN  37203-1304

                                        South Atlantic Private Equity Fund IV
                                        Limited Partnership
                                        and
                                        South Atlantic Private Equity Fund IV
                                        (Q.P.), Limited Partnership
                                        c/o Don Burton
                                        614 W. Bay Street, Suite 200
                                        Tampa, FL  33606

                                        Moore Global Investments, Ltd.
                                                 and
                                        Remington Investments Strategies, L.P.
                                        c/o Moore Capital Management, Inc.
                                        1251 Avenue of the Americas
                                        New York, NY  10020

                                       13
<PAGE>

                                        Attn:  Michael Heffernan

                                        Jack Tyrrell
                                        c/o Richland Ventures II, L.P.
                                        200 31st Avenue, N.
                                        Suite 200
                                        Nashville, Tennessee 37203

                                        W. Patrick Ortale, III
                                        200 31st Avenue, N.
                                        Suite 200
                                        Nashville, Tennessee 37203

                                        Vicki L. Brakebill
                                        1030 Berrington Circle
                                        Birmingham, Alabama  35242

                                        Michael P. DeChant, Sr.
                                        c/o Primis, Inc.
                                        7611 Standish Place
                                        Rockville, Maryland  20855

                                        William B. Britain
                                        c/o Primis, Inc.
                                        12 Perimeter Center East
                                        Suite 1220
                                        Atlanta, Georgia 30346

         If to Company to:              Primis, Inc.
                                        Suite 320
                                        11475 Great Oaks Way
                                        Alpharetta, GA  30022
                                        Attn:  James C. Schaper,
                                        President and CEO

or to such other address of which the addressee shall have notified the sender
in writing. Notices mailed in accordance with this section shall be deemed given
when mailed, and notices sent by overnight courier service shall be deemed given
when placed in the hands of a representative of such service.

         12. PARTIES IN INTEREST; ASSIGNMENT. Except as otherwise provided
herein, all covenants and agreements contained in this Agreement by or on behalf
of any of the parties to this Agreement shall bind

                                       14
<PAGE>

and inure to the benefit of their respective heirs, executors, successors, and
assigns, whether so expressed or not. Nothing in this Agreement, express or
implied, is intended to confer upon any party other than the parties hereto and
their respective successors and assigns any rights, remedies, obligations or
liabilities under or by reason of this Agreement. This Agreement is not
assignable and any purported assignment shall be null and void.

         13. CONSTRUCTION; GOVERNING LAW. The section headings contained in this
Agreement are inserted as a matter of convenience and shall not affect in any
way the construction of the terms of this Agreement. This Agreement shall be
governed by and interpreted in accordance with the laws of the Commonwealth of
Kentucky.

         14. ENTIRE AGREEMENT; AMENDMENT AND WAIVER. This Agreement, including
the Disclosure Letter and Exhibits hereto, constitutes and contains the entire
agreement between the parties hereto with respect to the transactions
contemplated hereby and supersedes any prior writing by the parties. Any term of
this Agreement may be amended and the observance of any term of this Agreement
may be waived (either generally or in a particular instance and either
retroactively or prospectively), only with the written consent of Company and
Investors (or its or his permitted assigns) holding at the time a majority in
interest of the outstanding Series B Preferred Stock. Any amendment or waiver
effected in accordance with this paragraph shall be binding upon each holder of
any securities purchased under this Agreement at the time outstanding (including
securities into which such securities have been converted), each future holder
of all such securities, and Company.

         15. SEVERABILITY. The invalidity or unenforceability of any provision
of this Agreement shall not affect the validity or enforceability of the
remaining provisions.

         16. COUNTERPARTS. This Agreement may be executed in one or more
counterparts, each of which shall be deemed an original, but all of which taken
together shall constitute one and the same Agreement.

         17. ATTORNEYS' FEES. If any action at law or in equity is necessary to
enforce or interpret the terms of this Agreement or any Ancillary Agreement, the
prevailing party shall be entitled to reasonable attorneys' fees, costs, and
disbursements in addition to any other relief to which such party may be
entitled.

         18. RIGHTS OF INVESTORS. Each holder of Series B Preferred Stock shall
have the absolute right to exercise or refrain from exercising any right or
rights that such holder may have by reason of this Agreement or any Series B
Preferred Stock, including without limitation the right to consent to the waiver
of any obligation of Company under this Agreement and to enter into an agreement
with Company for the purpose of modifying this Agreement or any agreement
effecting any such modification, and such holder shall not incur any liability
to any other holder or holders of Common Stock with respect to exercising or
refraining from exercising any such right or rights.

                                       15
<PAGE>

         19. EXCULPATION AMONG INVESTORS. Each Investor acknowledges that he is
not relying upon any person, firm, or corporation, other than Company and its
current officers and directors, in making its investment or decision to invest
in Company. Each Investor agrees that no other Investor nor the respective
agents of any other Investor shall be liable for any action heretofore or
hereafter taken or omitted to be taken by any of them in connection with the
Common Stock.

                                       16
<PAGE>

                  IN WITNESS WHEREOF, Company and Investors have caused this
Agreement to be executed as of the day and year first written above.

                                  "COMPANY"

                                  PRIMIS, INC.

                                  By:___________________________________
                                     James C. Schaper, President and
                                     Chief Executive Officer

                                  "INVESTORS"

                                  CASSELBERRY PARTNERS, L.P.

                                  By:___________________________________
                                  Title:________________________________

                                  JG FUNDING, LLC

                                  By:___________________________________
                                  Title:________________________________

                                  ______________________________________
                                  J. DAVID GRISSOM

                                  WINDCREST PARTNERS

                                  By:___________________________________
                                  A General Partner

                                       17
<PAGE>

                                  RICHLAND VENTURES II, L.P.

                                  By:___________________________________
                                  Its:__________________________________

                                  SOUTH ATLANTIC PRIVATE EQUITY FUND
                                  IV, LIMITED PARTNERSHIP

                                  By:  South Atlantic Private Equity Partners,
                                       Limited Partnership, Its General Partner

                                  By:___________________________________
                                  Its:  General Partner

                                  SOUTH ATLANTIC PRIVATE EQUITY FUND
                                  IV (Q.P.), LIMITED PARTNERSHIP

                                  By:  South Atlantic Private Equity Partners,
                                       Limited Partnership, Its General Partner

                                  By:___________________________________
                                  Its:  General Partner

                                  MOORE GLOBAL INVESTMENTS, LTD.

                                  By:___________________________________
                                  _________________ of Moore Capital
                                  Management
                                  Its:  Trading Advisor

                                       18
<PAGE>

                                  REMINGTON INVESTMENTS STRATEGIES,
                                  L.P.

                                  By:_______________________________________
                                     _____________ of Moore Capital
                                     Advisors, LLC

                                  Its:  General Partner

                                  __________________________________________
                                  JACK TYRRELL

                                  __________________________________________
                                  W. PATRICK ORTALE, III

                                  __________________________________________
                                  VICKI L. BRAKEBILL

                                  __________________________________________
                                  MICHAEL P. DECHANT, SR.

                                  __________________________________________
                                  WILLIAM B. BRITAIN

                                       19
<PAGE>

<TABLE>
<CAPTION>

                                   SCHEDULE 1

                              Investors' Investment

                                                              Number of Shares
                                                              of Series B                        Purchase
                  Investor                                    Preferred Stock                      Price
                  --------                                    ---------------                      -----
<S>                                                                <C>                          <C>
J. David Grissom
c/o Mayfair Capital
Suite 2510
400 West Market Street
Louisville, KY  40202                                               164,268                      985,608*

Windcrest Partners
49th Floor
122 East 42nd Street
New York, NY  10168-0130                                             87,813                      526,878

Richland Ventures II, L.P.
3100 West End Avenue
Suite 400
Nashville, TN  37203-1304                                            77,542                      465,252

South Atlantic Private Equity Fund IV,
Limited Partnership
614 W. Bay Street, Suite 200
Tampa, FL   33606                                                    32,568                      195,408

South Atlantic Private Equity Fund IV
(Q.P.), Limited Partnership
614 W. Bay Street, Suite 200
Tampa, FL  33606                                                     44,974                      269,844

Moore Global Investments, Ltd.
c/o Citco Fund Services (Bahamas), Ltd.
Bahamas Financial Center
Charlotte & Shirley Street
P.O. Box CB 13136
Nassau, Bahamas                                                      63,585                      381,510

Remington Investments Strategies, L.P.
1251 Avenue of the Americas

</TABLE>

<PAGE>

<TABLE>

<S>                                                                   <C>                          <C>
New York, NY  10020                                                   13,958                       83,748

Casselberry Partners, L.P.
c/o Douglas F. Cobb
600 West Main Street
Louisville, KY  40202                                                 52,650                      315,900

JG Funding, LLC
1850 National City Tower
101 South Fifth Street
Louisville, KY  40202                                                166,667                    1,000,002

Jack Tyrrell                                                           7,599                       45,594

W. Patrick Ortale, III                                                 3,799                       22,794

Vicki L. Brakebill                                                     5,968                       35,808

Michael P. DeChant, Sr.                                                2,000                       12,000

William B. Britain                                                     1,739                       10,484

</TABLE>

*    Purchase Price to be paid by cancellation of a promissory note from the
     Company to Mr. Grissom in a like amount.<PAGE>

                                                                   EXHIBIT 10.18

                                  PRIMIS, INC.
           THIRD AMENDED AND RESTATED 1997 EMPLOYEE STOCK OPTION PLAN

         1. PURPOSE. The purpose of this Plan is to strengthen the Company by
providing an additional means of retaining and attracting competent management
personnel and by providing to participating officers, directors and other key
employees of the Company added incentive for high levels of performance and for
unusual efforts to increase the earnings of the Company through the opportunity
for stock ownership offered by the Plan.

         2. DEFINITIONS. For purposes of this Plan, capitalized words and
phrases shall have the following meanings:

                  A. BOARD. The word "Board" means the Company's Board of
Directors.

                  B. CHANGE IN CONTROL. A "Change in Control" occurs if the
Company or any significant subsidiary of the Company, merges or consolidates,
and is not the surviving corporation in such merger or consolidation (or, if it
is the surviving corporation, there has been a change in the control of more
than fifty percent (50%) of the outstanding voting stock of the Company or such
subsidiary), or if all or substantially all of the Company's or any significant
subsidiary's assets are acquired by another corporation, person or entity, or if
fifty percent (50%) or more of the Company's outstanding voting stock is
acquired by a person, corporation or other entity which is not now a shareholder
of the Company. A significant subsidiary of the Company shall mean any
subsidiary of the Company which, as of the last day of the fiscal year
immediately preceding such Change in Control, constituted fifty percent (50%) or
more of the assets of the Company or contributed more than fifty percent (50%)
to the net income of the Company during such fiscal year.

                  C. CODE. The word "Code" means the Internal Revenue Code of
1986, as amended.

                  D. COMMON STOCK. The term "Common Stock" means the Company's
Common Stock, par value $0.01 per share, or the common stock or securities of a
Successor that have been substituted therefor pursuant to Section 8 hereof.

                  E. COMPANY. The word "Company" means Primis, Inc. a Georgia
corporation, f/k/a Premier Appraisals, Inc., with its principal place of
business at 11475 Great Oaks Way, Suite 220, Alpharetta, Georgia 30022.

                  F. DATE OF GRANT. The term "Date of Grant" means the effective
date on which an Option is awarded to an Optionee, as set forth in the Option
Agreement executed pursuant to Section 7 by the Optionee and by a member of the
Compensation Committee on behalf of the Company.

                  G. DISABILITY. The word "Disability" means, as defined by and
to be construed in accordance with Code Section 22(e)(3), any medically
determinable physical or mental impairment which

<PAGE>

can be expected to result in death or which has lasted or can be expected to
last for a continuous period of not less than twelve (12) months, and which
renders Optionee unable to engage in any substantial gainful activity. Optionee
shall not be considered to have a Disability unless Optionee furnishes proof of
the existence thereof in such form and manner, and at such time, as the
Compensation Committee may require.

                  H. EXCHANGE ACT. The term "Exchange Act" means the Securities
Exchange Act of 1934, as amended from time to time.

                  I. ISO. The acronym "ISO" means an option to purchase Common
Stock which at the time the option is granted qualifies as an incentive stock
option within the meaning of Code Section 422.

                  J. NSO. The acronym "NSO" means a nonstatutory stock option to
purchase Common Stock which at the time the option is granted does not qualify
as an ISO.

                  K. OPTION. The word "Option" means an ISO or NSO.

                  L. OPTION AGREEMENT. The term "Option Agreement" means an
agreement between the Company and an Optionee with respect to one or more
Options.

                  M. OPTION PRICE. The term "Option Price" means the price to be
paid for Common Stock upon the exercise of an Option granted under the Plan, in
accordance with Section 7.A hereof.

                  N. OPTIONEE. The word "Optionee" means an employee to whom
Options have been granted under the Plan.

                  O. OPTIONEE REPRESENTATIVE. The term "Optionee Representative"
means the personal representative of the Optionee's estate, and after final
settlement of the Optionee's estate, the successor or successors entitled
thereto by law.

                  P. PLAN. The word "Plan" means the Third Amended and Restated
Primis, Inc. 1997 Employee Stock Option Plan, as set forth herein, and as
amended from time to time.

                  Q. COMPENSATION COMMITTEE. The term "Compensation Committee"
means the committee appointed by the Board to administer the Plan, pursuant to
Section 4 hereof.

                  R. SUBSIDIARY. The word "Subsidiary" means, as defined in Code
Section 424(f), any corporation (other than the Company) in an unbroken chain of
corporations beginning with the Company if, at the time of the granting of an
Option under the Plan, each of the corporations other than the last corporation
in the unbroken chain owns stock possessing fifty percent (50%) or more of the
total combined voting power of all classes of stock of one of the other
corporations in such chain.

                                       2
<PAGE>

                  S. SUCCESSOR. The word "Successor" means the entity surviving
a merger or consolidation with the Company, or the entity that acquires all or
substantially all of the Company's assets or 50% or more of the Company's
outstanding voting stock (whether by merger, purchase or otherwise).

                  T. TEN PERCENT SHAREHOLDER. The term "Ten Percent Shareholder"
means an employee who, at the time an Option is granted, owns, or is deemed
within the meaning of Section 422(b)(6) of the Code to own, stock possessing
more than ten percent (10%) of the total combined voting power of all classes of
stock of the Company (or of its Subsidiary or parent (within the meaning of
Section 424(e) of the Code)).

         3. STOCK SUBJECT TO PLAN. Subject to adjustment as provided in Section
8 hereof, the aggregate number of shares of Common Stock which may be issued
under the Plan shall not exceed One Million Six Hundred Fifty Thousand
(1,650,000) shares. Authorized and unissued shares shall be delivered under the
Plan. If any Option expires or terminates for any reason, the shares of Common
Stock subject thereto shall again become available under the Plan to the extent
permitted by law.

         4. ADMINISTRATION. The Compensation Committee shall have full power and
authority to construe, interpret and administer the Plan and may from time to
time adopt such rules and regulations for carrying out the Plan as it may deem
proper and in the Company's best interests. The decision of a majority of the
members of the Compensation Committee shall constitute the decision of the
Compensation Committee and the Compensation Committee may act either at a
meeting at which a majority of the members of the Compensation Committee are
present, or by a writing signed by all of the members of the Compensation
Committee. The interpretation of any provisions of the Plan by the Compensation
Committee shall be final, conclusive, and binding upon all persons and the
officers of the Company shall place into effect and shall cause the Company to
perform its obligations under the Plan in accordance with the determinations of
the Compensation Committee in administering the Plan.

         5. GRANT OF OPTIONS.

                  A. COMPENSATION COMMITTEE'S AUTHORITY. Subject to the terms,
provisions and conditions of the Plan, the Compensation Committee shall have
exclusive jurisdiction: [i] to select the employees to whom Options shall be
granted; [ii] to authorize the granting of ISOs, NSOs or a combination of ISOs
and NSOs to employees; [iii] to determine the number of shares of Common Stock
subject to each Option; [iv] to determine the time or times when Options will be
granted, the manner in which each Option shall be exercisable, and the duration
of the exercise period; [v] to determine the time or times when Options shall
vest; [vi] to fix such other provisions of the Option Agreement as it may deem
necessary or desirable consistent with the terms of the Plan; and [vii] to
determine all other questions relating to the administration of the Plan.

                  B. $100,000 ISO EXERCISABILITY LIMITATION. Notwithstanding
Section 5.A hereof, the maximum aggregate fair market value of Common Stock
(determined as of the date the Option is

                                       3
<PAGE>

granted) with respect to which ISOs will first become exercisable by an Optionee
in any calendar year under all ISO plans of the Company and its Subsidiaries
shall not exceed $100,000. Any portion of an Option granted under the Plan in
excess of the foregoing limit shall constitute a NSO.

         6. ELIGIBILITY. Key employees of the Company and its Subsidiaries,
including officers and directors who are also employees of the Company or a
Subsidiary, are eligible to receive ISOs and NSOs under the Plan. Key employees
to whom Options may be granted under the Plan will be those selected by the
Compensation Committee from time to time who, in the sole discretion of the
Compensation Committee, have contributed in the past or who may be expected to
contribute materially in the future to the successful performance of the Company
and its Subsidiaries.

         7. TERMS OF OPTIONS. Each Option granted under the Plan shall be
evidenced by an Option Agreement signed by the Optionee and by a member of the
Compensation Committee on behalf of the Company. An Option Agreement shall
constitute a binding contract between the Company and the Optionee, and every
Optionee, upon acceptance of such Option Agreement, shall be bound by the terms
and restrictions of the Plan and of the Option Agreement. Such agreement shall
be subject to the following express terms and conditions and to such other terms
and conditions that are not inconsistent with the Plan as the Compensation
Committee may deem appropriate.

                  A. OPTION PRICE. The Option Price per share of Common Stock
shall be determined by the Compensation Committee at the time an Option is
granted. The Option Price for ISOs shall be not less than: [i] the fair market
value of Common Stock on the Date of Grant, or [ii] in the case of an ISO
granted to a Ten Percent Shareholder, one hundred ten percent (110%) of the fair
market value of Common Stock on the Date of Grant. The fair market value of
Common Stock shall be determined by:

                  [I] if the Common Stock is traded on the over-the-counter
         market, the closing high bid quotation for the Common Stock in the
         over-the-counter market as reported by the National Association of
         Securities Dealers Automated Quotation System, on the business day
         immediately preceding the Date of Grant;

                  [II] if the Common Stock is listed on a national securities
         exchange, the aver age of the closing prices of the Common Stock on the
         Composite Tape for the ten (10) consecutive trading days immediately
         preceding such given date; and

                  [III] if the Common Stock is neither traded on the
         over-the-counter market nor listed on a national securities exchange,
         such value as the Compensation Committee, in good faith, shall
         determine.

                  B. OPTION PERIOD. Subject to Section 7.C hereof, each Option
Agreement shall specify the period for which the Option thereunder is granted
and shall provide that the Option shall expire at the end of such period. The
Compensation Committee may extend such period provided that, in the

                                       4
<PAGE>

case of an ISO, such extension shall not in any way disqualify the Option as an
ISO without the Optionee's consent. In no case shall such period, including any
such extensions, exceed ten (10) years from the Date of Grant, provided,
however, that in the case of an ISO granted to a Ten Percent Stockholder, such
period, including extensions, shall not exceed five (5) years from the Date of
Grant.

                  C. LAPSE OF ISO. An ISO shall expire and no longer be
exercisable at the earliest of the following times:

                           [1] ten (10) years from the Date of Grant;

                           [2] five (5) years after the Date of Grant, if
         Optionee is a Ten Percent Shareholder on the Date of Grant;

                           [3] three (3) months after termination of employment
         with the Company or a Subsidiary for reasons other than Disability,
         discharge for cause, or death occurring less than three (3) months
         after termination of employment;

                           [4] one (1) year after termination of employment with
         the Company or a Subsidiary because of Optionee's Disability;

                           [5] one (1) year after the date of death if an
         Optionee dies [i] while employed by the Company or a Subsidiary, or
         [ii] within three (3) months after ceasing to be an employee of the
         Company or a Subsidiary; or

                           [6] immediately upon termination of employment
         through discharge for cause, as determined by the Compensation
         Committee in its sole discretion.

                  D. EXERCISE PERIOD. Except to the extent provided otherwise by
Section 7.H hereof, each stock Option granted under Section 5 hereof shall be
exercisable in accordance with the Option Agreement.

                  E. LEAVES OF ABSENCE. The Compensation Committee may, in its
discretion, treat all or any portion of any period during which an Optionee is
on military or on an approved leave of absence from the Company or a Subsidiary
as a period of employment of the Optionee by the Company or Subsidiary for
purposes of accrual of the Optionee's rights under the Plan. Notwithstanding the
foregoing, if a leave of absence exceeds ninety (90) days and reemployment is
not guaranteed by contract or statute, the Optionee's employment by the Company
or a Subsidiary for the purposes of the Plan shall be deemed to have terminated
on the 91st day of the leave.

                  F. MANNER OF EXERCISE. To exercise an Option, the Optionee
shall deliver to the Company: [i] seven (7) days' prior written notice
specifying the number of shares as to which the Option

                                       5
<PAGE>

is being exercised and, if determined by counsel for the Company to be
necessary, repre senting that such shares are being acquired for investment
purposes only and not for purpose of resale or distribution; [ii] an executed
Shareholders' Agreement in the form attached hereto as EXHIBIT A; [iii] an
executed Noncompetition Agreement in a form satisfactory to the Compensation
Committee; and [iv] payment by the Optionee, or a broker-dealer (as provided in
Section 7.G hereof), for such shares of the Option Price for the number of
shares with respect to which the Option is exercised. On or before the
expiration of the seven (7) day notice period, and provided that all conditions
precedent contained in the Plan are satisfied, the Company shall, without
transfer or issuance tax or other incidental expenses to Optionee, deliver to
Optionee, at the offices of the Company, or at such other place as may be
mutually acceptable, or, at the election of the Company, by certified mail
addressed to Optionee at Optionee's address as shown in the records of the
Company, a certificate or certificates for the Common Stock. Options are
exercisable only in whole shares, and fractional share interests shall be
treated in the manner described in the Option Agreement. If Optionee fails to
accept delivery of the Common Stock, the Optionee's rights to exercise the
applicable portion of the Option shall terminate.

                  G. PAYMENT FOR SHARES. Except as otherwise provided in this
Section 7, the Option Price for the Common Stock shall be paid in full when the
Option is exercised. Subject to such rules as the Committee may impose and the
terms of the Option Agreement, the Option Price may be paid in whole or in part
in [i] cash, [ii] certified or cashier's check, [iii] whole shares of Common
Stock owned by the Optionee evidenced by negotiable certificates, [iv] such
other consideration as shall constitute lawful consideration for the issuance of
Common Stock and be approved by the Committee (including without limitation, the
delivery of a copy of irrevocable instructions from the Optionee to a broker
registered under the Securities Exchange Act of 1934, reasonably acceptable to
the Committee, to sell certain of the Option Shares purchased upon exercise of
the Option, or to pledge said shares as collateral for a loan, and to promptly
deliver to the Corporation the amount of sale or loan proceeds necessary to pay
such purchase price), or [v] by a combination of such methods of payment. If
payment of the Option Price is made in Common Stock, the value of the Common
Stock used for payment of the Option Price shall be the fair market value of the
Common Stock, determined in accordance with Section 7.A hereof, on the business
day preceding the day written notice of exercise is delivered to the Company.

                  H. ACCELERATION. Notwithstanding the provisions of Sections
7.B or D hereof to the contrary, if there is a Change in Control, the exercise
dates of all outstanding Options shall accelerate so that each Option
outstanding may be exercised on or after the date of the Change in Control.

                  I. ISOS. Each Option Agreement which provides for the grant of
an ISO shall contain such terms and provisions as the Compensation Committee
deems necessary or desirable to qualify such Option as an ISO within the meaning
of Code Section 422.

                  J. TRANSFERABILITY OF OPTIONS. During Optionee's lifetime, the
Option shall be exercisable only by Optionee, and neither the Option nor any
right hereunder shall be transferable except by will or by the laws of descent
and distribution. The Option may not be subject to execution or other

                                       6
<PAGE>

similar process. If Optionee attempts to alienate, assign, pledge, hypothecate
or otherwise dispose of the Option or any of Optionee's rights hereunder, except
as provided herein, or in the event of any levy, attachment, execution or
similar process upon the rights or interests hereby conferred, the Company may,
in its sole and absolute discretion, terminate the Option by notice to Optionee
and it shall thereupon become null and void.

         8. ADJUSTMENT OF SHARES. In the event of capital adjustment after the
effective date of the Plan in the Common Stock of the Company by reason of any
reorganization, recapital ization, stock split, stock dividend, combination or
exchange of shares, merger or consolidation, or any other change (after the
effective date of the Plan) in the nature or number of shares of Common Stock of
the Company, a proportionate adjustment shall be made in the maximum number and
kind of shares which may be delivered under the Plan, and in the Option Price
under and the number and kind of shares of Common Stock covered by outstanding
Options granted under the Plan. By virtue of such a capital adjustment, the
price of any share under Option shall be adjusted so that there will be no
change in the aggregate purchase price payable upon exercise of any such Option.
Such determination by the Compensation Committee shall be conclusive.

                  Without limiting the generality of the foregoing, if [a] there
is a Change in Control of the Company, and [b] as a result of the transactions
contemplated by the Change in Control, a Successor will acquire all or
substantially all of the assets or 50% of more of the Company's outstanding
voting stock, then the kind of shares of common stock which shall be subject to
the Plan and to each outstanding Option shall automatically be converted into
and replaced by shares of common stock, or such other class of equity securities
having rights and preferences no less favorable than common stock of the
Successor, and the number of shares subject to the Options and the purchase
price per share upon exercise of the Options shall be correspondingly adjusted,
so that, by virtue of such Change in Control of the Company, each Optionee shall
have the right to purchase [i] that number of shares of the Successor which, as
of the date of the Change in Control, have a fair market value equal to the fair
market value of the shares of the Company theretofore subject to an Option, [ii]
for a purchase price per share which, when multiplied by the number of shares of
the Successor subject to the Option, shall equal the aggregate exercise price at
which the Optionee could have acquired shares of the Company under such Option.

                  The granting of an Option pursuant to this Plan shall not
affect in any way the right and power of the Company to make adjustments,
reorganizations, reclassifications, or changes of its capital or business
structure or to merge, consolidate, dissolve, liquidate, sell or transfer all or
any part of its business or assets; provided, however, that the Company shall
not, and shall not permit its Subsidiaries to, recommend or agree or consent to
a transaction or series of transactions which would result in a Change of
Control of the Company unless and until the person or persons acquiring or
succeeding to assets or capital stock of the Company or its Subsidiaries as a
result of such transaction or transactions agrees to be bound by the terms of
the Plan so far as it pertains to Options theretofore granted and agrees to
assume and perform the obligations of the Company and its Successor under the
Plan.

                                       7
<PAGE>

         9. COMPLIANCE WITH OTHER LAWS AND REGULATIONS.  Upon the
exercise of an Option at a time when there is not in effect a registration
statement under the Securities Act of 1933, as amended, and any applicable state
securities laws (the "Securities Laws") relating to the shares of Common Stock
issuable upon exercise thereof and available for delivery a prospectus meeting
the requirements of the Securities Laws, the shares of Common Stock may be
issued only if the Optionee or Optionee Representative represents and warrants
in writing to the Company that the shares being purchased are being acquired for
investment and not with a view to the distribution thereof. The shares of the
Common Stock shall contain such legends or other re strictive endorsements as
counsel for the Company shall deem necessary or proper. No shares of Common
Stock shall be purchased upon the exercise of any Option unless and until there
shall have been satisfied any applicable requirements of the Securities and
Exchange Commission or other regulatory agencies having jurisdiction and of any
exchanges upon which stock of the Company may be listed.

         10. NO RIGHTS AS SHAREHOLDER. No Optionee or Optionee's Representative
shall have any rights as a shareholder with respect to Common Stock subject to
Optionee's Option before the date of issuance to the Optionee of a certificate
or certificates for such shares.

         11. NO RIGHTS TO CONTINUED EMPLOYMENT. The Plan and any Option granted
under the Plan shall not confer upon any Optionee any right with respect to
continuance of employment by the Company or any Subsidiary, nor shall it
interfere in any way with the right of the Company or any Subsidiary by which an
Optionee is employed to terminate Optionee's employment at any time.

         12. TERMINATION. The Plan shall terminate on May 29, 2007, ten (10)
years from the earlier of the date it was adopted by the Board or approved by
the shareholders of the Company, and may be terminated at any earlier time by
the Compensation Committee. No Option shall be granted after termination of the
Plan. Termination of the Plan, however, shall not affect the validity of any
Option theretofore granted under the Plan.

         13. AMENDMENT. The Board shall have the right, at any time, to amend,
suspend or terminate the Plan in any respect that it may deem to be in the best
interests of the Company, except that, without approval by shareholders of the
Company holding not less than a majority of the votes represented and entitled
to be voted at a duly held meeting of the Company's shareholders, no amendment
shall be made if shareholder approval is necessary to qualify the Plan under the
Securities and Exchange Commission Rule 16b-3. No amendment of the Plan,
however, may, without the consent of the Optionee or Optionee Representative,
make any changes in any outstanding Option theretofore granted under the Plan
which would adversely affect the rights of such Optionee or Optionee
Representative.

         14. TAX WITHHOLDING. Upon the exercise of any Option granted under the
Plan, or upon the disposition of any Common Stock acquired by the exercise of an
ISO granted under the Plan within two (2) years from the Date of Grant or one
(1) year after such Common Stock is trans ferred to the Optionee, the Company
shall have the right to require Optionee to remit to the Company an amount

                                       8
<PAGE>

sufficient to satisfy all federal, state and local withholding tax requirements,
or, alternatively, the Company shall have the right to retain Common Stock
otherwise payable to the Optionee pursuant to exercise of an Option in an amount
sufficient to satisfy such withholding requirements, before the delivery to the
Optionee of any certificate(s) for shares of Common Stock.

         15. GOVERNING LAW. This Plan and the Option Agreements entered into
under the Plan shall be governed by, and construed in accordance with, the laws
of the State of Georgia.

         16. EFFECTIVE DATE. The effective date of the Plan shall be May 30,
1997. The Plan was adopted by the Board on May 30, 1997, and approved by
stockholders of the Company holding not less than a majority of the shares
represented and entitled to vote on May 30, 1997. The Amended and Restated Plan
was adopted by the Board on June 16, 1998 and approved by the stockholders of
the Company holding not less than a majority of the shares represented and
entitled to vote on June 16, 1998. The Second Amended and Restated Plan was
adopted by the Board on May 27, 1999 and approved by the stockholders of the
Company holding not less than a majority of the shares represented and entitled
to vote on June 15, 1999. This Third Amended and Restated Plan was adopted by
the Board on November 24, 1999 and approved by the stockholders of the Company
holding not less than a majority of the shares represented and entitled to vote
on November 24, 1999.

                                    PRIMIS, INC.

                                    By: __________________________________
                                        Leslie H. Schreiner, Secretary and
                                        Chief Financial Officer

ATTEST:

_____________________

                                       9
<PAGE>

                                    EXHIBIT A

                     (COMMON STOCK SHAREHOLDERS' AGREEMENT)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00000-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00000-of-00352.parquet"}]]